New data back long-term use of Novartis’ Aimovig in migraine
The data add to real world and long-term evidence showing efficacy of Aimovig for migraine prevention across the migraine spectrum
Read More
Tag: PERISCOPE
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
